Cover Image
市場調查報告書

玻尿酸產品市場(單劑、三劑週期、五劑週期) - 全球產業分析、市場規模、佔有率、成長、趨勢及預測

Hyaluronic Acid Products Market (Single-Injection, Three-Injection Cycle and Five-Injection Cycle) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

出版商 Transparency Market Research 商品編碼 301492
出版日期 內容資訊 英文 106 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
玻尿酸產品市場(單劑、三劑週期、五劑週期) - 全球產業分析、市場規模、佔有率、成長、趨勢及預測 Hyaluronic Acid Products Market (Single-Injection, Three-Injection Cycle and Five-Injection Cycle) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
出版日期: 2014年04月30日 內容資訊: 英文 106 Pages
簡介

玻尿酸,用到身體送營養促進體內組織的水分保持的糖胺聚糖這個物質,在關節和免疫疾病系等裡(上)存在著。玻尿酸作為關節軟骨重要的因素表面塗層著軟骨細胞周圍。

本報告提供全球玻尿酸產品市場相關調查,市場概要和2013∼2019年的預測,各地區趨勢,彙整加入此市場的企業簡介,為您概述為以下內容。

第1章 簡介

第2章 摘要整理

第3章 市場概要

  • 簡介和市場定義
  • 市場趨勢
    • 促進要素
    • 阻礙要素
    • 市場機會
  • 波特五力分析
  • 市場魅力度分析
  • 各主要企業市場佔有率分析

第4章 各產品市場

  • 概要
  • 單劑週期產品
  • 三劑週期產品
  • 五劑週期產品

第5章 各用途市場

  • 概要
  • 退化性關節炎
  • 眼科
  • 皮膚填充劑
  • 膀胱輸尿管逆流

第6章 各地區市場

  • 概要
  • 北美
  • 歐洲
  • 亞太地區
  • 其他

第7章 建議

第8章 企業簡介

  • Alcon, Inc.
  • Allergan, Inc.
  • Anika Therapeutics, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Ferring Pharmaceuticals, Inc.
  • Fidia Farmaceutici SpA
  • GALDERMA S.A.
  • Hyaltech Ltd.
  • LifeCore Biomedical LLC,
  • Meiji Seikafaruma株式會社
  • Merz Aesthetics, Inc.
  • Sanofi
  • Salix Pharmaceuticals, Inc.
  • Seikagaku Corporation
  • Shanghai Jingfeng Pharmaceutical Co., Ltd.
  • Smith & Nephew plc
  • TRB CHEMEDICA INTERNATIONAL SA
  • Zimmer Holdings, Inc.

圖表

目錄

Hyaluronic acid (HA) is a glycosaminoglycan that helps in transportation of nutrients through the body and facilitate water retention in body tissue. It is naturally found in body - in joints, eye cavity, immune system and others. HA was observed to be an important component of articular cartilage where it is present in the form of a coat around each chondrocyte. This report studies the global hyaluronic acid products market by types of products, applications and the major geographic markets. Products market is segmented as single-injection, three-injection cycle and five-injection cycle. Similarly, applications market is segmented as osteoarthritis, ophthalmic surgery, dermal fillers and vesicoureteral reflux (VUR).

Geographically, the hyaluronic acid products market report segments the global market into four main regions namely, North America, Europe, Asia-Pacific and Rest of the World (RoW). The market sizes and forecasts for the period 2011 to 2019 in terms of revenue (USD million), considering 2012 as the base year, have been provided for each technology type, application type and geographic region, along with their sub-segments (if any). The hyaluronic acid products market report also provides the compounded annual growth rate (CAGR %) during the forecast period 2013 to 2019 for all the aforementioned segments.

The market overview section of the hyaluronic acid products market report discusses the market dynamics with respect to market drivers, restraints and opportunities. This section also covers market attractiveness analysis (by geography) and Porter's five forces analysis for the global hyaluronic acid products market. Market share (%) for the major players operating in this market has also been provided for the year 2012, followed by a list of recommendations for the existing and new players to enter and enhance their market shares. The report concludes with the company profiles of key players operating in various segments of the market. Each company profile includes the business overview, financial overview, product portfolio, business strategies and recent developments of the respective company. Some of the prominent players in the hyaluronic acid products market that have been profiled in this report include Allegran Inc., Anika Therapeutics, Inc., Merz Aesthetics, Inc., Sanofi (Genzyme) and Seikagaku.

The global hyaluronic acid products market is segmented as follows:

Hyaluronic Acid Products Market, by Products

  • Single-injection
  • Three-injection cycle
  • Five-injection cycle

Hyaluronic Acid Products Market, by Applications

  • Osteoarthritis
  • Ophthalmic
  • Dermal Fillers
  • Vesicoureteral Reflux (VUR)

Hyaluronic Acid Products Market, by Geography

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World (RoW)

Table of Contents

Chapter 1 Introduction

  • 1.1 Report Description
  • 1.2 Market Segmentation
  • 1.3 Research Methodology
    • 1.3.1 Sources
    • 1.3.2 Assumptions and Stipulations

Chapter 2 Executive Summary

  • 2.1 Market Snapshot: Global Hyaluronic Acid Products Market (2013 & 2019)
    • 2.1.1 Global Hyaluronic Acid Products Market, by Products, 2012 (USD Million)
  • 2.2 Comparative Analysis: Global Hyaluronic Acid Products Market, By Geography, 2012 and 2019 (Value %)

Chapter 3 Market Overview

  • 3.1 Introduction and Market Definition
  • 3.2 Market Dynamics
    • 3.2.1 Drivers
    • 3.2.2 Restraints
    • 3.2.3 Market Opportunities
  • 3.3 Porter's Five Forces Analysis: Global Hyaluronic Acid Products Market
    • 3.3.1 Bargaining power of suppliers
    • 3.3.2 Bargaining power of buyers
    • 3.3.3 Threat of Substitutes
    • 3.3.4 Threat of New Entrants
    • 3.3.5 Competitive Rivalry
  • 3.4 Market Attractiveness Analysis
    • 3.4.1 Market Attractiveness Analysis: Global Hyaluronic Acid Products Market
  • 3.5 Global Market Share Analysis for the Hyaluronic Acid Products, by Key Players, 2012 (Value %)
    • 3.5.1 Global Market Share by Key Players, 2012 (Value %)

Chapter 4 Global Hyaluronic Acid Products Market, by Products

  • 4.1 Overview
    • 4.1.1 Global Hyaluronic Acid Products Market Revenue, by Products, 2011 - 2019 (USD Million)
  • 4.2 Single-Injection Cycle Products
    • 4.2.1 Global Single-Injection Cycle Products Market Revenue, 2011 - 2019 (USD Million)
  • 4.3 Three-Injection Cycle Products
    • 4.3.1 Global Three-Injection Cycle Products Market Revenue, 2011 - 2019 (USD Million)
  • 4.4 Five-Injection Cycle Products
    • 4.4.1 Global Five-Injection Cycle Products Market Revenue, 2011 - 2019 (USD Million)

Chapter 5 Global Hyaluronic Acid Products Market, by Applications

  • 5.1 Overview
    • 5.1.1 Global Hyaluronic Acid Products Market Revenue, by Applications, 2011 - 2019 (USD Million)
  • 5.2 Osteoarthritis
    • 5.2.1 Global Hyaluronic Acid Products Market Revenue, by Osteoarthritis Application, 2011 - 2019 (USD Million)
  • 5.3 Ophthalmic
    • 5.3.1 Global Hyaluronic Acid Products Market Revenue, by Ophthalmic Application, 2011 - 2019 (USD Million)
  • 5.4 Dermal Fillers
    • 5.4.1 Global Hyaluronic Acid Products Market Revenue, by Dermal Filler Application, 2011 - 2019 (USD Million)
  • 5.5 Vesicoureteral Reflux (VUR)
    • 5.5.1 Global Hyaluronic Acid Products Market Revenue, by Vesicoureteral Reflux Application, 2011 - 2019 (USD Million)

Chapter 6 Global Hyaluronic Acid Products Market, by Geography

  • 6.1 Overview
    • 6.1.1 Global Hyaluronic Acid Products Market Revenue, by Geography, 2011 - 2019 (USD Million)
  • 6.2 North America
    • 6.2.1 North America Hyaluronic Acid Products Market Revenue, 2011 - 2019 (USD Million)
  • 6.3 Europe
    • 6.3.1 Europe Hyaluronic Acid Products Market Revenue, 2011 - 2019 (USD Million)
  • 6.4 Asia-Pacific
    • 6.4.1 Asia-Pacific Hyaluronic Acid Products Market Revenue, 2011 - 2019 (USD Million)
  • 6.5 Rest of the World (RoW)
    • 6.5.1 RoW Hyaluronic Acid Products Market Revenue, 2011 - 2019 (USD Million)

Chapter 7 Recommendations

  • 7.1 Market Strategy for Success
    • 7.1.1 Focus on improving technology in order to increase the accuracy and reduce side-effects
    • 7.1.2 Multinational companies established partnership with the local professional/organization to expand their business
  • 7.2 Barriers to be considered
    • 7.2.1 High cost is a barrier for sufficient market expansion

Chapter 8 Company Profiles

  • 8.1 Alcon, Inc.
    • 8.1.1 Company Overview
    • 8.1.2 Financial Overview
    • 8.1.3 Product Portfolio
    • 8.1.4 Business Strategies
    • 8.1.5 Recent Developments
  • 8.2 Allergan, Inc.
    • 8.2.1 Company Overview
    • 8.2.2 Financial Overview
    • 8.2.3 Product Portfolio
    • 8.2.4 Business Strategies
    • 8.2.5 Recent Developments
  • 8.3 Anika Therapeutics, Inc.
    • 8.3.1 Company Overview
    • 8.3.2 Financial Overview
    • 8.3.3 Product Portfolio
    • 8.3.4 Business Strategies
    • 8.3.5 Recent Developments
  • 8.4 F. Hoffmann-La Roche Ltd.
    • 8.4.1 Company Overview
    • 8.4.2 Financial Overview
    • 8.4.3 Product Portfolio
    • 8.4.4 Business Strategies
    • 8.4.5 Recent Developments
  • 8.5 Ferring Pharmaceuticals, Inc.
    • 8.5.1 Company Overview
    • 8.5.2 Financial Overview
    • 8.5.3 Product Portfolio
    • 8.5.4 Business Strategies
    • 8.5.5 Recent Developments
  • 8.6 Fidia Farmaceutici SpA
    • 8.6.1 Company Overview
    • 8.6.2 Financial Overview
    • 8.6.3 Product portfolio
    • 8.6.4 Business Strategies
    • 8.6.5 Recent developments
  • 8.7 GALDERMA S.A.
    • 8.7.1 Company Profile
    • 8.7.2 Financial Overview
    • 8.7.3 Product Portfolio
    • 8.7.4 Business Strategies
    • 8.7.5 Recent Developments
  • 8.8 Hyaltech Ltd.
    • 8.8.1 Company Overview
    • 8.8.2 Financial Overview
    • 8.8.3 Product Portfolio
    • 8.8.4 Business Strategies
    • 8.8.5 Recent Developments
  • 8.9 LifeCore Biomedical LLC,
    • 8.9.1 Company Overview
    • 8.9.2 Financial Overview
    • 8.9.3 Product Portfolio
    • 8.9.4 Business Strategies
    • 8.9.5 Recent Developments
  • 8.10 Meiji Seika Pharma Co., Ltd.
    • 8.10.1 Company Profile
    • 8.10.2 Financial Overview
    • 8.10.3 Product Portfolio
    • 8.10.4 Business Strategies
    • 8.10.5 Recent Developments
  • 8.11 Merz Aesthetics, Inc.
    • 8.11.1 Company Overview
    • 8.11.2 Financial Overview
    • 8.11.3 Product Portfolio
    • 8.11.4 Business Strategies
    • 8.11.5 Recent Developments
  • 8.12 Sanofi
    • 8.12.1 Company Overview
    • 8.12.2 Financial Overview
    • 8.12.3 Product Portfolio
    • 8.12.4 Business Strategies
    • 8.12.5 Recent Developments
  • 8.13 Salix Pharmaceuticals, Inc.
    • 8.13.1 Company Overview
    • 8.13.2 Financial Overview
    • 8.13.3 Product Portfolio
    • 8.13.4 Business Strategies
    • 8.13.5 Recent Developments
  • 8.14 Seikagaku Corporation
    • 8.14.1 Company Overview
    • 8.14.2 Financial Overview
    • 8.14.3 Product Portfolio
    • 8.14.4 Business Strategies
    • 8.14.5 Recent Developments
  • 8.15 Shanghai Jingfeng Pharmaceutical Co., Ltd.
    • 8.15.1 Company Overview
    • 8.15.2 Financial Overview
    • 8.15.3 Product Portfolio
    • 8.15.4 Business Strategies
    • 8.15.5 Recent Developments
  • 8.16 Smith & Nephew plc
    • 8.16.1 Company Overview
    • 8.16.2 Financial Overview
    • 8.16.3 Product Portfolio
    • 8.16.4 Business Strategies
    • 8.16.5 Recent Development
  • 8.17 TRB CHEMEDICA INTERNATIONAL SA
    • 8.17.1 Company Overview
    • 8.17.2 Financial Overview
    • 8.17.3 Product Portfolio
    • 8.17.4 Business Strategies
    • 8.17.5 Recent Developments
  • 8.18 Zimmer Holdings, Inc.
    • 8.18.1 Business Overview
    • 8.18.2 Financial Overview
    • 8.18.3 Product Portfolio
    • 8.18.4 Business Strategies
    • 8.18.5 Recent Developments

List of Figures

  • FIG. 1 Hyaluronic Acid Products: Market Segmentation
  • FIG. 2 Global Hyaluronic Acid Products Market, by Products, 2012 (USD Million)
  • FIG. 3 Comparative Analysis: Global Hyaluronic Acid Products Market, by Geography, 2012 and 2019 (Value %)
  • FIG. 4 Porter's Five Forces Analysis: Global Hyaluronic Acid Products Market
  • FIG. 5 Production Methods of Hyaluronic acid
  • FIG. 6 Market Attractiveness Analysis: Global Hyaluronic Acid Products Market
  • FIG. 7 Market Share Analysis: Hyaluronic Acid Products Market, 2012 (Value %)
  • FIG. 8 Comparative Analysis: Types of Hyaluronic Acid Products
  • FIG. 9 Global Single-Injection Products Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 10 Global Three-Injection Cycle Products Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 11 Global Five-Injection Cycle Products Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 12 Global Hyaluronic Acid Products Market Revenue, by Osteoarthritis Application, 2011 - 2019 (USD Million)
  • FIG. 13 Global Hyaluronic Acid Products Market Revenue, by Ophthalmic Application, 2011 - 2019 (USD Million)
  • FIG. 14 Global Hyaluronic Acid Products Market Revenue, by Dermal Filler Application, 2011 - 2019 (USD Million)
  • FIG. 15 Global Hyaluronic Acid Products Market Revenue, by Vesicoureteral Reflux Application, 2011 - 2019 (USD Million)
  • FIG. 16 North America Hyaluronic Acid Products Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 17 Europe Hyaluronic Acid Products Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 18 Asia-Pacific Hyaluronic Acid Products Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 19 RoW Hyaluronic Acid Products Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 20 Alcon, Inc., Annual Revenue: 2010 - 2012 (USD Million)
  • FIG. 21 Allergan, Inc., Annual Sales Revenue: 2010 - 2012 (USD Million)
  • FIG. 22 Anika Therapeutics, Inc., Annual Revenue: 2010- 2012 (USD Million)
  • FIG. 23 F. Hoffmann-La Roche Ltd., Annual Revenue: 2010 - 2012 (USD Million)
  • FIG. 24 Galderma S.A., Annual Revenue: 2010 - 2012 (USD Million)
  • FIG. 25 Lifecore Biomedical LLC., Annual Revenue: 2010- 2012 (USD Million)
  • FIG. 26 Meiji Seika Pharma Co., Ltd., Annual Revenue: 2010 - 2012 (USD Million)
  • FIG. 27 Merz Aesthetics Inc., Annual revenue: 2010 - 2012 (USD Million)
  • FIG. 28 Sanofi, Annual Revenue: 2010 - 2012 (USD Million)
  • FIG. 29 Salix Pharmaceuticals, Inc., Annual Revenue: 2010 - 2012 (USD Million)
  • FIG. 30 Seikagaku Corporation, Annual Revenue: 2010 - 2012 (USD Million)
  • FIG. 31 Smith & Nephew PLC, Annual Revenue: 2010 - 2012 (USD Million)
  • FIG. 32 Zimmer Holdings. Inc., Annual Revenue: 2010 - 2012 (USD Million)

List of Tables

  • TABLE 1 Market Snapshot: Global Hyaluronic Acid Products Market (2013 & 2019)
  • TABLE 2 Global Hyaluronic Acid Products Market Revenue, by Products, 2011 -2019 (USD Million)
  • TABLE 3 Global Hyaluronic Acid Products Market Revenue, by Applications, 2011 -2019 (USD Million)
  • TABLE 4 Global Hyaluronic Acid Products Market Revenue, by Geography, 2011 -2019 (USD Million)
Back to Top